Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Ultimovacs ULTIMOO Jan 23, 2020 57.00 0.00   
 Umida B UMIDAB Jan 23, 2020 2.48 +1.22   
 Unibap UNIBAP Jan 23, 2020 28.00 -1.06   
 Unlimited Travel Group UTG Jan 23, 2020 27.00 +2.27   
 Upsales Technology UPSALE Jan 23, 2020 25.40 -0.20   
 Urb-it URBIT Jan 23, 2020 1.15 -4.96   
 Vadsbo Switchtech VADS Jan 23, 2020 2.72 -0.73   
 VBG Group B VBGB Jan 23, 2020 188.50 +1.89   
 Venue Retail Group B VRGB Jan 23, 2020 0.57 -2.06   
 Veoneer VNESDB Jan 23, 2020 129.40 +0.39   
 Verisec VERI Jan 23, 2020 98.40 -1.60   
 Vertical Ventures VEVEN Jan 23, 2020 0.07 +5.11   
 Vertiseit B VERTB Jan 23, 2020 20.60 +0.98   
 Veteranpoolen VPABB Jan 23, 2020 19.80 -2.94   
 VibroSense Dynamics B VSDB Jan 23, 2020 8.88 +0.91   
 Vicore Pharma Holding VICO Jan 23, 2020 14.80 0.00   
 Viking Supply Ships B VSSABB Jan 23, 2020 80.00 +1.27   
 Vindico Group VSEC Jan 23, 2020 0.80 +6.71   
 Vistin Pharma VISTINO 0.00 0.00   
 Vitec Software Group B VITB Jan 23, 2020 205.00 -2.38   
 Vitrolife VITR Jan 23, 2020 206.40 -1.05   
 Volati VOLO Jan 23, 2020 44.05 0.00   
 Volati Pref VOLOPREF Jan 23, 2020 694.00 +0.29   
 Volvo A VOLVA Jan 23, 2020 155.00 -1.84   
 Volvo B VOLVB Jan 23, 2020 155.20 -1.83   
 Vostok Emerging Finance VEMFSDB Jan 23, 2020 3.41 +0.89   
 Vostok New Ventures VNVSDB Jan 23, 2020 71.00 -1.39   
 Vow ASA SSHIPO Jan 23, 2020 28.50 0.00   
 Västsvensk Logistik VASLOG Jan 23, 2020 105.00 0.00   
 Wallenius Wilhelmsen WALWILO Jan 23, 2020 27.34 0.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK